Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma markets in the eastern Democratic Republic of Congo

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the Belgian Cooperation Agency of the ARES (Academie de Recherche et d-Enseignement Superieur) [grant COOP-CONV-20-022] and by the PADISS (Projet d-Appui au Developpement Integre du Systeme de Sante du Nord-Kivu) in the frame of the Programme de renforcement de l-offre et developpement de l-acces aux soins de sante (PRO DS) which is funded by the European Development Fund (FED11) For this work, Mitangala Ndeba Prudence (MNP), Musubao Tsongo Edgar (MTS), and Kahindo Mbeva Jean Bosco (KMJB) were supported by the ULB Collaboration Nord Kivu, Democratic Republic of Congo (Grant Goma-Nord Kivu-2021) The funders did not play any role in the study design, collection, analysis, and interpretation of data, manuscript writing, or the decision to submit the paper for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was reviewed and approved by the Ethical Review Committee of the Universite Catholique de Bukavu (number UCB/CIES/NC/02312021). All participants or their guardians (in the case of children) provided written consent before enrolment.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes